Solution for infusions Volyutenz is shown for:
- Prevention and treatment of a relative or absolute hypovolemia or shock.
- Prevention of arterial hypotension (including at induction of epidural or spinal anesthesia).
- Procedures, including extracorporal blood circulation (including on the device "heart and lungs").
Structure
Active ingredients: 1000 ml of solution contain:
- gelatin to polysuccinate - 40.0 g;
- sodium of acetate of trihydrate - 3.675 g;
- sodium of chloride - 4.590 g;
- potassium of chloride - 0.403 g;
- Calcii chloridum a dihydrate - 0.133 g;
- magnesium of chloride of hexahydrate - 0.203 g;
- sodium of hydroxide - 0.980 g
Excipients: water for injections.
Contraindication
- Hypersensitivity to medicine components.
- Overhydratation.
- Hypervolemia.
- Heavy heart failure.
- Heavy renal failure.
- Recently postponed myocardial infarction.
- Heavy violations of fibrillation.
- Hypernatremia.
- Hyperpotassemia.
- Dehydration.
Route of administration
Intravenous administration.
Before introduction solution should be warmed up to body temperature.
before introduction of solution needs to remove withAt introduction of the medicine Volyutenz by infusion under pressure (including by means of a cuff or the infusional pump) all air from a container and a system for input as there is a danger of development of an air embolism during infusion.
Feature of application
Pregnant
Medicine should be applied during pregnancy only on emergency to indications and only when the potential advantage for mother exceeds potential risk for a fruit.
Children
children are recommended to use Drug aged from 6 years.
OverdoseOverdose or too fast introduction of the medicine Volyutenz can lead
to an inadvertent hypervolemia and a circulator overload, the heart tied with the subsequent dysfunction and lungs. Symptoms of a circulator overload include, in particular, a headache, short wind and kongestiya of a jugular vein. At overdose there is a danger of an overhydratation, ratio distortion of electrolytic and acid-base balance.
At emergence of the first symptoms of a circulator overload infusion should be stopped immediately. Symptomatic treatment.
Side effects
After administration of the medicine Volyutenz, as well as any colloidal deputies of volume, can develop anaphylactoid reactions of varying severity.
Anaphylactoid reactions of the I-II degree include fever, sudden face reddening and necks, the naggers, a local erythema, paresthesias, a headache, inflows, pour (urticaria), hypostasis of mucous membranes, tachycardia, arterial hypotension, an asthma, cough, nausea, vomiting.
InteractionMixing of the medicine Volyutenz with other medicines can result
in incompatibility. Volyutenz it is impossible to enter along with fat emulsions. It is incompatible with the solutions containing phosphates and carbonates.
patients who at the same time apply medicines which can cause a delay of potassium or sodium Should be careful.
Storage conditionsto Store
in original packing at a temperature not above 25 °C. not to freeze
. To use immediately after opening.
Expiration date - 2 years.
Characteristics | |
Active ingredients | Suktsinirovanny gelatin, Potassium chloride, Calcii chloridum, Magnesium chloride, Sodium acetate trihydrate, Sodium hydroxide, Sodium chloride |
Applicant | Yury-pharmaceutical |
Code of automatic telephone exchange | B05AA06 gelatin Drugs |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | SERUMVERK BERNBURG AG |
Quantity in packing | 500 ml |
Release form | solution for infusions |
Route of administration | Infusional |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Volyutenz |
Volyutenz solution for inf. quarrystone. 500 ml
- Product Code: 176714
- In Stock
- Ready to ship
-
$34.36